GlassScriptPhysician profile
Jason Michael Phillips
NPI 1417120387
$352,873.94
in general payments reported to CMS, 2019-2025
55 companies · $1,708 in 2025
The $1,708 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68K · 2020: $172K · 2021: $41K · 2022: $57K · 2023: $13K · 2024: $1,523 · 2025: $1,708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $4,043 · Education: $379 · Travel and Lodging: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,200.00 |
| Food and Beverage | $4,043.33 |
| Education | $379.39 |
| Travel and Lodging | $187.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $155,410.36 | 2019-2024 | Urolift |
| Neotract INC. | $153,040.76 | 2019-2020 | |
| Intuitive Surgical, INC. | $32,348.31 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $1,887.16 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $1,605.81 | 2019-2025 | Xtandi, Myrbetriq |
| Uromedica, Incorporated | $1,290.00 | 2019 | |
| Janssen Biotech, INC. | $894.55 | 2019-2025 | Erleada |
| Biotissue Holdings INC. | $628.17 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $460.75 | 2019-2025 | |
| Axonics, INC. | $432.90 | 2021-2024 | Axonics |
| Myriad Genetic Laboratories, INC. | $419.29 | 2020-2025 | Prolaris, Myrisk |
| Urogen Pharma, INC. | $376.32 | 2020-2025 | Jelmyto |
| Procept Biorobotics Corporation | $361.52 | 2022-2025 | Aquabeam Robotic System |
| Palette Life Sciences, INC. | $305.34 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $293.14 | 2019-2024 | Xiaflex |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $253.47 | 2019-2025 | |
| Pfizer INC. | $245.05 | 2019-2024 | |
| Olympus America INC. | $226.42 | 2019-2025 | Itind System |
| Ethicon US, LLC | $223.01 | 2021-2025 | Ethicon, Echelon Flex, Vistaseal |
| Coloplast Corp | $213.13 | 2019-2024 | |
| Amgen INC. | $134.88 | 2019-2021 | |
| Boston Scientific Corporation | $126.72 | 2019-2024 | Ams 700, Rezum Generator |
| Janssen Pharmaceuticals, INC | $108.85 | 2019-2021 | |
| Blue Earth Diagnostics | $106.49 | 2019-2024 | |
| Endo USA, INC. | $102.55 | 2024-2025 | Xiaflex, Aveed |
| Myovant Sciences INC. | $101.96 | 2021-2022 | |
| Telix Pharmaceuticals | $101.08 | 2022-2024 | Illuccix |
| Comsort, INC | $100.00 | 2019 | |
| Medtronic USA, INC. | $86.81 | 2019 | |
| Sumitomo Pharma America, INC. | $86.18 | 2024-2025 | Gemtesa, Orgovyx |
| Calyxo, INC. | $85.55 | 2024-2025 | Cvac Aspiration System |
| Progenics Pharmaceuticals, INC. | $79.90 | 2022-2024 | |
| Convatec INC. | $68.68 | 2022-2025 | |
| Allergan, INC. | $62.17 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $56.67 | 2024-2025 | Imfinzi |
| Becton, Dickinson and Company | $56.60 | 2023-2024 | Bard Urinary Drainage Bag, Arista Ah Flexitip |
| Steris Corporation | $45.10 | 2025 | |
| Laborie Medical Technologies Corp. | $39.73 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Healthtronics Stone Solutions, LLC | $39.18 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $38.61 | 2020-2021 | |
| Uroviu Corporation | $35.90 | 2023 | Uro-G Flexible Cystoscope |
| Ferring Pharmaceuticals INC. | $29.15 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $28.06 | 2022 | |
| Foundation Medicine, INC. | $27.57 | 2020 | |
| Merck Sharp & Dohme LLC | $26.18 | 2023 | Keytruda, Lynparza |
| Photocure INC | $24.48 | 2024 | Cysview |
| Antares Pharma, INC. | $23.49 | 2019 | |
| Travere Therapeutics, INC. | $23.04 | 2021 | |
| Alnylam Pharmaceuticals INC. | $22.50 | 2023 | Oxlumo |
| Immunitybio, INC. | $19.99 | 2024 | |
| Stryker Corporation | $16.21 | 2020 | |
| Tolmar, INC. | $14.63 | 2023 | |
| Kci USA, INC. | $13.92 | 2023 | Ranger |
| Sagent Pharmaceuticals | $12.92 | 2023 | Glydo |
| Clarus Therapeutics INC. | $12.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.